Literature DB >> 26207565

Tissue distribution of pretomanid in rat brain via mass spectrometry imaging.

Adeola Shobo1, Dominika Bratkowska1, Sooraj Baijnath1, Suhashni Naiker1, Anou M Somboro1, Linda A Bester2, Sanil D Singh2, Tricia Naicker1, Hendrik G Kruger1, Thavendran Govender1.   

Abstract

1. Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) combines the sensitivity and selectivity of mass spectrometry with spatial analysis to provide a new dimension for histological analyses of the distribution of drugs in tissue. Pretomanid is a pro-drug belonging to a class of antibiotics known as nitroimidizoles, which have been proven to be active under hypoxic conditions and to the best of our knowledge there have been no studies investigating the distribution and localisation of this class of compounds in the brain using MALDI MSI. 2. Herein, we report on the distribution of pretomanid in the healthy rat brain after intraperitoneal administration (20 mg/kg) using MALDI MSI. Our findings showed that the drug localises in specific compartments of the rat brain viz. the corpus callosum, a dense network of neurons connecting left and right cerebral hemispheres. 3. This study proves that MALDI MSI technique has great potential for mapping the pretomanid distribution in uninfected tissue samples, without the need for molecular labelling.

Entities:  

Keywords:  Drug distribution; MALDI MSI; nitroimidazole

Mesh:

Substances:

Year:  2015        PMID: 26207565     DOI: 10.3109/00498254.2015.1067935

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  11 in total

1.  Neuroprotective potential of Linezolid: a quantitative and distribution study via mass spectrometry.

Authors:  Sooraj Baijnath; Adeola Shobo; Linda A Bester; Sanil D Singh; Gert Kruger; Per I Arvidsson; Tricia Naicker; Thavendran Govender
Journal:  J Mol Histol       Date:  2016-06-21       Impact factor: 2.611

Review 2.  Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System.

Authors:  Nithya Srinivas; Kaitlyn Maffuid; Angela D M Kashuba
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

3.  Post heroin dose tissue distribution of 6-monoacetylmorphine (6-MAM) with MALDI imaging.

Authors:  Belin G Teklezgi; Annapurna Pamreddy; Sooraj Baijnath; Nirmala D Gopal; Tricia Naicker; Hendrik G Kruger; Thavendran Govender
Journal:  J Mol Histol       Date:  2017-05-26       Impact factor: 2.611

4.  Evidence for the presence of clofazimine and its distribution in the healthy mouse brain.

Authors:  Sooraj Baijnath; Suhashni Naiker; Adeola Shobo; Chivonne Moodley; John Adamson; Bongani Ngcobo; Linda A Bester; Sanil Singh; Hendrik G Kruger; Tricia Naicker; Thavendran Govender
Journal:  J Mol Histol       Date:  2015-07-25       Impact factor: 2.611

5.  Small molecule distribution in rat lung: a comparison of various cryoprotectants as inflation media and their applicability to MSI.

Authors:  Sooraj Baijnath; Adeola Shobo; Linda A Bester; Sanil D Singh; Gert Kruger; Tricia Naicker; Thavendran Govender
Journal:  J Mol Histol       Date:  2016-01-13       Impact factor: 2.611

Review 6.  New Drugs for the Treatment of Tuberculosis.

Authors:  Elisa H Ignatius; Kelly E Dooley
Journal:  Clin Chest Med       Date:  2019-12       Impact factor: 4.967

7.  Bedaquiline has potential for targeting tuberculosis reservoirs in the central nervous system.

Authors:  Annapurna Pamreddy; Sooraj Baijnath; Tricia Naicker; Sphamandla Ntshangase; Sipho Mdanda; Hlengekile Lubanyana; Hendrik G Kruger; Thavendran Govender
Journal:  RSC Adv       Date:  2018-03-28       Impact factor: 4.036

8.  Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis.

Authors:  Katharine E Stott; Justin Beardsley; Sarah Whalley; Freddie Mukasa Kibengo; Nguyen Thi Hoang Mai; Nguyễn Lê Nhu' Tùng; Ngo Thi Kim Cuc; Ruwanthi Kolamunnage-Dona; William Hope; Jeremy Day
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

9.  Delamanid or pretomanid? A Solomonic judgement!

Authors:  Saskia E Mudde; Anna M Upton; Anne Lenaerts; Hannelore I Bax; Jurriaan E M De Steenwinkel
Journal:  J Antimicrob Chemother       Date:  2022-03-31       Impact factor: 5.790

Review 10.  Profiling Pretomanid as a Therapeutic Option for TB Infection: Evidence to Date.

Authors:  Stephani L Stancil; Fuad Mirzayev; Susan M Abdel-Rahman
Journal:  Drug Des Devel Ther       Date:  2021-06-28       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.